Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?

OBJECTIVES--The objectives were to assess (a) the comparative merits of commonly used disease modifying drugs in the treatment of rheumatoid arthritis (RA) and (b) the influence of age, gender, and disease duration on the outcome of treatment. METHODS--Collected analysis (meta-analysis) was performe...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Ann Rheum Dis
Principais autores:	Capell, H A, Porter, D R, Madhok, R, Hunter, J A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005066/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8100702/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.6.423
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!